Evidence map›Paper›PMID 39099605›Full record

ArticleBiochemistry and biophysics reports2024

Characterization of high-affinity antibodies against the surface Gc protein of

Pyeonghwa Jeon, Bin Yoo, Yoonji Kim, So-Young Lee, Hye-Min Woo, Hee-Young Lim, Joo-Yeon Lee, Sora Park, Hansaem Lee

Abstract read
In one paragraph

Article in Biochemistry and biophysics reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Multidimensional mechanisms of SFTSV-host interactions: viral protein functions, mFrontiers in cellular and infection microbiology · 2026
    Review
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Pyeonghwa JeonDivision of Emerging Virus & Vector Research, Center for Emerging Virus Research, Republic of Korea.
Bin YooNew Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do, 28160, Republic of Korea.
Yoonji KimNew Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do, 28160, Republic of Korea.
So-Young LeeDivision of Emerging Virus & Vector Research, Center for Emerging Virus Research, Republic of Korea.
Hye-Min WooDivision of Emerging Virus & Vector Research, Center for Emerging Virus Research, Republic of Korea.
Hee-Young LimDivision of Emerging Virus & Vector Research, Center for Emerging Virus Research, Republic of Korea.
Joo-Yeon LeeCenter for Emerging Virus Research, Korea National Institute of Infectious Diseases, Korea National Institute of Health, Korea Disease Control and Prevention Agency, Cheonju-si, Chungcheongbuk-do, 28159, Republic of Korea.
Sora ParkNew Drug Development Center, Osong Medical Innovation Foundation, Cheongju-si, Chungcheongbuk-do, 28160, Republic of Korea.
Hansaem LeeDivision of Emerging Virus & Vector Research, Center for Emerging Virus Research, Republic of Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe fever with thrombocytopenia syndrome virus (SFTSV) or

Indexed as

GlycoproteinMonoclonal antibodiesPhlebovirus genusSerological diagnosisSFTSV

Identifiers

PMID39099605
PMCPMC11296068

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.